Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Clinical Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Concomitant Hypertension and Hyperlipidemia
Sponsor: Daewoong Pharmaceutical Co. LTD.
Summary
This study aims to evaluate the efficacy and safety of co-administration of DWC202206 and DWC202207 in patients with concomitant hypertension and hyperlipidemia.
Official title: A Randomized, Double-blind, Multicenter Phase 3 Trial to Evaluate the Efficacy and Safety of Co-administration of DWC202206 and DWC202207 in Patients With Hypertension and Dyslipidemia
Key Details
Gender
All
Age Range
19 Years - 80 Years
Study Type
INTERVENTIONAL
Enrollment
214
Start Date
2023-02-23
Completion Date
2024-09-10
Last Updated
2026-04-30
Healthy Volunteers
No
Conditions
Interventions
(D) DWC202206
Drug of DWC202206 A mg
(D) DWC202207
Drug of DWC202207 B/C mg
(P) DWC202206
Placebo of DWC202206 A mg
(P) DWC202207
Placebo of DWC202207 B/C mg
Locations (1)
Kangbuk Samsung Hospital
Seoul, South Korea